CL vs MO
Colgate-Palmolive and Altria, both Consumer Defensive
Altria is the larger company at $120B against $72B. On trailing earnings MO is the cheaper of the two at a P/E of 15.1 against 35.6, a gap that is only a bargain if the two are growing at similar rates. Over the past year MO returned +16% against +13% for CL. The RyuScore puts MO ahead, 77 against 74 out of 100.
| Figure | CL | MO |
|---|---|---|
| Last close | $89.98 | $71.67 |
| Market cap | $72B | $120B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 35.6 | 15.1 |
| Dividend yield | 2.3% | 5.8% |
| 1-year return | +13% | +16% |
| 5-year return | +30% | +114% |
| RyuScoresector-relative, 1–10 | 74/100 | 77/100 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Colgate-Palmolive
Revenue of $5.4B in Q2 2026, net income $693M. Its largest reported line is Latin America, 33% of the disclosed total.
Altria
Revenue of $6.1B in Q2 2026, net income $2.3B. Its largest reported line is Smokeable Products, 88% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or see the correlation.